Article
Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis
2022-12-07
Abstract excerpt
<h4>Background: </h4> Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors is a rare, relatively new and potentially fatal clinical entity, characterized by metabolic acidosis with normal or only moderately increased glycemia. Its mechanisms are not completely understood, but involve increased ketogenesis and complex renal metabolic dysfunction, resulting in both ketoacidosis and hyperchloremic acidos...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2d409b0-28e3-586c-b46c-0d68524ecfc9
- DOI
- 10.21203/rs.3.rs-2308651/v1
